Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 23;117(4):qiaf002.
doi: 10.1093/jleuko/qiaf002.

Neutrophil extracellular traps capture the human pathogen, Candida albicans, in blood and delay hyphal transformation

Miyuki Sakuma  1   2 , Adam Viens  3 , Alex Hopke  1   2   4 , Daniel J Floyd  3 , Musie Ghebremichael  4   5 , Michael K Mansour  3   4 , Daniel Irimia  1   2   4
Affiliations

Neutrophil extracellular traps capture the human pathogen, Candida albicans, in blood and delay hyphal transformation

Miyuki Sakuma et al. J Leukoc Biol. .

Abstract

In tissues, neutrophils neutralize Candida albicans through phagocytosis and delay C. albicans hyphae growth by deploying neutrophil extracellular traps (NETs). However, in the bloodstream, the dynamic interactions between NETs and C. albicans are far less understood. Here, we employ a microfluidic assay and measure a significant increase in intact NETs in blood within 3 h after adding C. albicans yeast or hyphae. We show that C. albicans yeast can be captured efficiently on NETs, thereby delaying the transition to hyphal growth. We measure higher amounts of intact NETs in blood samples from invasive candidiasis patients compared to healthy participants, both with and without stimulation. These findings suggest that both C. albicans yeast and hyphae in the bloodstream stimulate NET release, potentially aiding in their removal from the blood.

Keywords: candidemia; host-pathogen; innate immunity; microfluidic.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement. None declared.

References

    1. Teoh F, Pavelka N. How chemotherapy increases the risk of systemic candidiasis in cancer patients: current paradigm and future directions. Pathogens. 2016:5(1):6. 10.3390/pathogens5010006 - DOI - PMC - PubMed
    1. Enoch DA, Yang H, Aliyu SH, Micallef C. The changing epidemiology of invasive fungal infections. Methods Mol Biol. 2017:1508:17–65. 10.1007/978-1-4939-6515-1_2 - DOI - PubMed
    1. Jenks JD, Cornely OA, Chen SC-A, Thompson GR 3rd, Hoenigl M. Breakthrough invasive fungal infections: who is at risk? Mycoses. 2020:63(10):1021–1032. 10.1111/myc.13148 - DOI - PubMed
    1. Cheng M-F, Yang Y-L, Yao T-J, Lin C-Y, Liu J-S, Tang R-B, Yu K-W, Fan Y-H, Hsieh K-S, Ho M, et al. Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species. BMC Infect Dis. 2005:5(1):22. 10.1186/1471-2334-5-22 - DOI - PMC - PubMed
    1. Dixit D, Jen P, Maxwell TD, Smoke S, McCracken JA, Cardinale-King M, Haribhakti A, Patel P, Cani E, Choi SC, et al. Risk factors and clinical outcomes of candidemia associated with severe COVID-19. Crit Care Explor. 2022:4(9):e0762. 10.1097/CCE.0000000000000762 - DOI - PMC - PubMed